Completed PHASE2 INTERVENTIONAL 1-arm NCT01343953

Cord Blood Transplantation in Severe Aplastic Anemia (APCORD)

A Prospective Phase II Study to Evaluate Cord Blood Transplantation in Inherited or Acquired Severe Aplastic Anemia Refractory or in Relapse After Immunosuppressive Therapy

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Absence of an HLA Identical Donor Acquired Aplastic Anemia Hereditary Diseases Relapse

Interventions Cord Blood Transplantation

Updated 6 times since 2017 Last updated: Jun 13, 2017 Started: May 31, 2011 Primary completion: Jun 30, 2017 Completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Absence of an HLA Identical Donor and Acquired Aplastic Anemia, this trial is completed. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jul 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France